Advertisement
UK markets closed
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • CRUDE OIL

    78.83
    +0.45 (+0.57%)
     
  • GOLD FUTURES

    2,324.00
    -0.20 (-0.01%)
     
  • DOW

    38,960.86
    +76.60 (+0.20%)
     
  • Bitcoin GBP

    49,835.26
    -996.15 (-1.96%)
     
  • CMC Crypto 200

    1,323.09
    +28.42 (+2.19%)
     
  • NASDAQ Composite

    16,283.18
    -49.38 (-0.30%)
     
  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     

What’s the Latest on Teva’s Fremanezumab?

What’s the Latest on Teva’s Fremanezumab?

Teva’s (TEVA) much-awaited migraine drug, Fremanezumab, is in late-stage trials for the treatment of cluster headaches. The company provided an update regarding its Enforce Phase III clinical development program for the treatment of cluster headaches on June 15.